Zobrazeno 1 - 10
of 438
pro vyhledávání: '"Marya D. Zilberberg"'
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Inappropriate empiric antimicrobial treatment (IET) contributes to worsened outcomes. While IET’s differential impact across types of nosocomial pneumonia (NP: non-ventilated [nvHABP], ventilated [vHABP] hospital-acquired and ve
Externí odkaz:
https://doaj.org/article/5a6cdb3e826342658199ec64cb0be666
Publikováno v:
Antibiotics, Vol 13, Iss 2, p 123 (2024)
Bloodstream infections (BSIs) arising in the intensive care unit (ICUs) present a significant challenge and we completed a narrative review of the emerging literature on this issue. Multiple reports document that these infections are associated with
Externí odkaz:
https://doaj.org/article/f96788c2d52c4f7b89c4265057a32675
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Complicated urinary tract infection (cUTI) is common among hospitalized patients. Though carbapenems are an effective treatment in the face of rising resistance, overuse drives carbapenem resistance (CR). We hypothesized that resi
Externí odkaz:
https://doaj.org/article/9ca8b3ae5ebf459bae94e6393e6cfdfe
Autor:
Andrew F. Shorr, Marya D. Zilberberg
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/43be4d65212a4febbc25aa31ba7bb2fd
Publikováno v:
Journal of the American College of Emergency Physicians Open, Vol 3, Iss 2, Pp n/a-n/a (2022)
Abstract Objective There are >1 million emergency department visits and 100,000 admissions with urinary tract infection (UTI) annually in the United States. A fraction of total UTI volume, complicated (cUTI) costs the health care system over $3.5 bil
Externí odkaz:
https://doaj.org/article/65fe31185dd64f88912765df67ec750c
Autor:
Marya D. Zilberberg, MD, MPH, Brian H. Nathanson, PhD, Laura A. Puzniak, PhD, MPH, Noah W. D. Zilberberg, Andrew F. Shorr, MD, MPH, MBA
Publikováno v:
Critical Care Explorations, Vol 4, Iss 4, p e0667 (2022)
OBJECTIVES:. Nosocomial pneumonia (NP) remains a costly complication of hospitalization fraught with subsequent complications and augmented resource utilization. Consisting of ventilated hospital-acquired bacterial pneumonia (vHABP), nonventilated ho
Externí odkaz:
https://doaj.org/article/380732a2bf1a4e19829377e1531d0b7b
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0276192 (2022)
IntroductionNosocomial pneumonia (NP) remains associated with excess morbidity and mortality. The effect of NP on measures such as re-admission at 30 days remains unclear. Moreover, differing types of NP may have varying impacts on re-admissions.Meth
Externí odkaz:
https://doaj.org/article/f5a28d984e394040a12e40f17047cb54
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Using aggregated data available on the interactive website from the Agency for Healthcare Research and Quality’s Healthcare Cost and Utilization Project Network (HCUPnet), we examined the annual volume of invasive aspergillosis
Externí odkaz:
https://doaj.org/article/8049597b897c4c1a9374a9ffc01c6a5f
Autor:
Sarah Haessler, Ning Guo, Abhishek Deshpande, Marya D. Zilberberg, Tara Lagu, Peter K. Lindenauer, Peter B. Imrey, Michael B. Rothberg
Publikováno v:
Crit Care Med
OBJECTIVES: Compare the clinical practice and outcomes in severe community-acquired pneumonia (sCAP) patients to those in non-sCAP patients using guideline-defined criteria for sCAP. DESIGN: Retrospective observational cohort study. SETTING: One hund
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 6, Iss 1, Pp 1-7 (2017)
Abstract Background Enterobacteriaceae are common pathogens in pneumonia, sepsis and urinary tract infection (UTI). Though rare, carbapenem resistance (CRE) among these organisms complicates efforts to ensure adequate empiric antimicrobial therapy. I
Externí odkaz:
https://doaj.org/article/8b9f752ccaaf4b9891a2507963904dcd